share_log

Rapport Therapeutics, Inc. | 8-A12B: Registration of a class of securities on a national securities exchange

SEC ·  Jun 4 16:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more